1. Repository of OAI
Ελληνικά   English  
Saved Searches

Discover

Search


Current filters:



Clear current filters  or Add more filters

View Option


Results 1-10 of 12 (Search time: 0.033 seconds).

  Prevalence of vascular disease in metabolic syndrome using three proposed definitions (Journal article)

  Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects (Journal article)

  The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate (Journal article)

  Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure (Journal article)

  Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia (Journal article)

  Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A (Journal article)

  Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjects (Journal article)

  Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study (Journal article)

  Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study (Journal article)

  Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study (Journal article)